Chieri, Italy

Stefano Buttiglieri

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Fresenius Medical Care Deutschland Gmbh. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stefano Buttiglieri. Retrieved from https://idiyas.com/inventor/stefano-buttiglieri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0



Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Stefano Buttiglieri

Introduction

Stefano Buttiglieri is a notable inventor based in Chieri, Italy. He has made significant contributions to the field of medical science, particularly in the area of liver progenitor cells. His work has the potential to impact regenerative medicine and therapeutic applications.

Latest Patents

Stefano Buttiglieri holds a patent related to human liver pluripotent progenitor cell lines. This invention involves cell lines that express hepatic cell markers such as albumin and α-fetoprotein, while lacking markers typical of oval stem cells. The patent also discloses methods for isolating these cell lines, differentiating them into various cell lineages, and conditional immortalization. Furthermore, it outlines the use of these cell lines for preparing medicaments with osteogenic differentiation activity or liver injury regeneration activity.

Career Highlights

Stefano Buttiglieri is currently employed at Fresenius Medical Care Deutschland GmbH, where he continues to advance his research and innovations. His work is pivotal in the development of new therapeutic strategies for liver-related conditions.

Collaborations

Stefano collaborates with esteemed colleagues, including Maria Beatriz Herrera Sanchez and Benedetta Bussolati. These partnerships enhance the research and development efforts in the field of regenerative medicine.

Conclusion

Stefano Buttiglieri's innovative work in liver progenitor cells exemplifies the intersection of science and technology in medicine. His contributions are paving the way for future advancements in regenerative therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…